HSA — authorised 22 August 1962
- Marketing authorisation holder: WYETH AYERST
- Status: likely_approved
🇸🇬 Grifulvin V in Singapore
HSA authorised Grifulvin V on 22 August 1962
Marketing authorisation
Grifulvin V in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Singapore
Frequently asked questions
Is Grifulvin V approved in Singapore?
Yes. HSA authorised it on 22 August 1962.
Who is the marketing authorisation holder for Grifulvin V in Singapore?
WYETH AYERST holds the Singaporean marketing authorisation.